Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.885 USD | -0.26% | -10.90% | -46.32% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.3M |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | -21M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.42
x | P/E ratio 2025 * |
-0.38
x | Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.41% |
Latest transcript on TRACON Pharmaceuticals, Inc.
1 day | -0.26% | ||
1 week | -10.90% | ||
Current month | -78.13% | ||
1 month | -79.57% | ||
3 months | -53.92% | ||
6 months | -45.35% | ||
Current year | -46.32% |
Managers | Title | Age | Since |
---|---|---|---|
Charles Theuer
CEO | Chief Executive Officer | 60 | 06-06-30 |
Scott Brown
DFI | Director of Finance/CFO | 43 | 15-07-31 |
James L. Freddo
CTO | Chief Tech/Sci/R&D Officer | 69 | 20-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Mattingly
BRD | Director/Board Member | 66 | 14-12-25 |
Director/Board Member | 54 | 20-03-18 | |
Stephen Worland
BRD | Director/Board Member | 66 | 15-02-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.88 | -0.53% | 3 008 |
24-04-24 | 1.89 | +2.16% | 65,903 |
24-04-23 | 1.85 | +1.65% | 55,123 |
24-04-22 | 1.82 | -7.14% | 143,958 |
24-04-19 | 1.96 | -7.11% | 250,528 |
Delayed Quote Nasdaq, April 25, 2024 at 09:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.32% | 4.3M | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-22.16% | 29.36B | |
+57.03% | 24.49B | |
-12.21% | 17.31B | |
-17.55% | 11.62B | |
-13.96% | 11.31B | |
-44.23% | 11.26B | |
+6.14% | 8.31B |
- Stock Market
- Equities
- TCON Stock